Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans

Circulation

Volumn 93, Issue 2, 1996, Pages 266-271

  Cooper, Christopher J ^a,b   Landzberg, Michael J ^a   Anderson, Todd J ^a   Charbonneau, Francois ^a   Creager, Mark A ^a   Ganz, Peter ^a   Selwyn, Andrew P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

acetylcholine; endothelium; endothelium derived factors; lung; nitric oxide

Indexed keywords

ACETYLCHOLINE; N(G) METHYLARGININE; NITRIC OXIDE; PHENYLEPHRINE;

ADULT; AGED; ARTERY DILATATION; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HUMAN; LUNG ANGIOGRAPHY; LUNG ARTERY; LUNG VASCULAR RESISTANCE; MALE; PRIORITY JOURNAL; SYNCOPE; THORAX PAIN; VASCULAR ENDOTHELIUM;

EID: 0030049840     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.2.266     Document Type: Article

References (38)

1. Ignarro LJ, Buga GM, Wood KS, Byrns RE. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A. 1987;84:9265-9269.
2. G-methylarginine. Biochetn Biophys Res Commun. 1990;170: 96-103.
3. Ogata M, Ohe M, Katayose D, Takishima T. Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. Am J Physiol. 1992;262:H691-H697.
4. Moore P, Velvis H, Fineman JR, Soifer SJ, Heymann MA. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. J Appl Physiol. 1992;73:2151-2157.
5. Liu S, Crawley DE, Barnes PJ, Evans TW. Endothelium-derived relaxing factor inhibits hypoxic pulmonary vasoconstriction in rats. Am Rev Respir Dis. 1991;143:32-37.
6. Archer SL, Tolins JP, Raij L, Weir EK. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun. 1989;164:1198-1205.
7. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992; 262:H1365-H1371.
8. Perrella MA, Hildebrand FL, Margulies KB, Burnett JC. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol. 1991;261:323-328.
9. Celermajer DS, Dollery C, Burch M, Deanfield JE. Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. Circulation. 1994;89:2041-2044.
10. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2040.
11. Doucette JW, Cord PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 1992;85: 1899-1911.
12. Labovitz AJ, Anthonis DM, Cravens TL, Kern MJ. Validation of volumetric flow measurements by means of a Doppler-tipped coronary angioplasty guide wire. Am Heart J. 1993;126:1456-1461.
13. Uehata A, Matsuguchi T, Bittl JA, Orav J, Meredith IT, Anderson TJ, Selwyn AP, Ganz P, Yeung AC. Accuracy of electronic digital calipers compared with quantitative angiography in measuring arterial diameter. Circulation. 1993;88:1724-1729.
14. ω-Nitro-L-arginine methylester selectively inhibits pulmonary vasodilator responses to acetylcholine and bradykinin. J Appl Physiol. 1991;71:2026-2031.
15. Abman SH, Chatfield BA, Hall SL, McMurthy IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol. 1990;259:1921-1927.
16. Fineman JR, Heymann MA, Soifer SJ. N-Nitro-L-arginine attenuates endothelium-dependent pulmonary vasodilation in lambs. Am J Physiol. 1991;260:1299-1306.
17. Fineman JR, Chang R, Soifer SJ. EDRF inhibition augments pulmonary hypertension in intact newborn lambs. Am J Physiol. 1992; 262:1365-1371.
18. Moore P, Velvis H, Fineman JR, Soifer SJ, Heymann MA. EDRF inhibition attenuates the increase in pulmonary blood flow due to oxygen ventilation in fetal lambs. J Appl Physiol. 1992;73:2151-2157.
19. Persson MG, Gustafsson LE, Wiklund NP, Moncada S, Hedqvist P. Endogenous nitric oxide as a probable modulator of pulmonary circulation and hypoxic pressor response in vivo. Acta Physiol Scand. 1990;140:449-457.
20. Fineman JR, Crowley MR, Heymann MA, Soifer SJ. In vivo attenuation of endothelium-dependent pulmonary vasodilation by methylene blue. J Appl Physiol. 1991;71:735-741.
21. Archer SL, Rist K, Nelson DP, DeMaster EG, Cowan N, Weir EK. Comparison of the hemodynamic effects of nitric oxide and endothelium-dependent vasodilators in intact lungs. J Appl Physiol. 1990; 68:735-747.
22. Tseng CM, Mitzner W. Antagonists of EDRF attenuate acetylcholine-induced vasodilation in isolated hamster lungs. J Appl Physiol. 1992;72: 2162-2167.
23. Hasunuma K, Yamaguchi T, Rodman DM, O'brien RF, McMurtry IF. Effects of inhibitors of EDRF and EDHF on vasoreactivity of perfused rat lungs. Am J Physiol. 1991;260:97-104.
24. Nishiwaki K, Nyhan DP, Rock P, Desai PM, Peterson WP, Pribble CG, Murray PA. N-Nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs. Am J Physiol. 1992; 262:1331-1337.
25. G-Monomethyl-L-arginine causes nitric oxide synthesis in isolated arterial rings: trouble in paradise. Biochem Biophys Res Commun. 1992;188:590-596.
26. Greenberg B, Rhoden K, Barnes PJ. Endothelium-dependent relaxation of human pulmonary arteries. Am J Physiol. 1987;252: 434-438.
27. Brashers VL, Peach MJ, Rose CE. Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest. 1988;82:1295-1502.
28. Cherry PD, Gillis CN. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung. J Pharmacol Exp Ther. 1987;241:516-520.
29. Harris P. Influence of acetylcholine on the pulmonary arterial pressure. Br Heart J. 1957;19:272-278.
30. Wood P, Besterman EM, Towers MK, McIlroy MB. The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis. Br Heart J. 1957;19:279-286.
31. Landzberg MJ, Vita JA, Yeung AC, Cannon CP, Ganz P, Selwyn AP. Endothelium-dependent modulation of pulmonary vascular tone in man. J Am Coll Cardiol. 1992;19(suppl):2A.
32. Celemajer DS, Cullen S, Deanfield JE. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993;87:440-446.
33. Porter TR, Taylor DO, Cycan A, Fields J, Bagley CW, Pandian NG, Mohanty PK. Endothelium-dependent pulmonary artery responses in chronic heart failure: influence of pulmonary hypertension. J Am Coll Cardiol. 1993;22:1418-1424.
34. Rees DD, Palmer RMJ, Hudson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 1989;96:418-424.
35. Sakuma I, Stuehr DJ, Gross SS, Nathan C, Levi R. Identification of arginine as a precursor of endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988;85:8664-8667.
36. Zellers TM, McCormick J, Wu Y. Interaction among ET-1, endothelium-derived nitric oxide and prostacyclin in pulmonary arteries and veins. Am J Physiol. 1994;267:H139-H147.
37. Shaul PW, Kinane B, Farrar MA, Buja LM, Magness RR. Prostacyclin production and mediation of adenylat cyclase activity in the pulmonary artery, alterations after prolonged hypoxia in the rat. J Clin Invest. 1991;88:447-455.
38. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.